Table 1

Clinical characteristics of 18 patients with gout enrolled in the study.

No

Age (years)

Co-morbidities

Number of affected joints

Number of annual attacks

Therapy of attacks


1

75

DM2, VH, COPD

2

2

Colchicine

2

80

DM2, VH, CHD

4

5

Colchicine

3

62

DM2, VH, obesity

1

1

Colchicine

4

80

DM2, COPD, CHD

1

1

Colchicine

5

45

VH, obesity

1

1

Colchicine

6

70

VH

1

1

Colchicine

7

67

DM2, VH, CHD

7

5

NSAIDs

8

65

VH, obesity

1

1

Colchicine

9

62

VH

1

1

Colchicine

10

55

VH, obesity

2

1

Colchicine

11

80

DM2, VH

2

2

NSAIDs

12

32

Obesity

4

6

NSAIDs

13

70

VH

1

1

Colchicine

14

70

DM2, VH

3

2

Colchicine

15

68

Obesity

1

3

Colchicine

16

52

DM2, CRD

1

10

Colchicine

17

69

CRD

5

4

Colchicine

18

46

CRD

1

5

Colchicine


CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease; CRD, chronic renal disease; DM2, diabetes mellitus type 2; NSAIDs, non-steroidal anti-inflammatory drugs; VH, vascular hypertension.

Mylona et al. Arthritis Research & Therapy 2012 14:R158   doi:10.1186/ar3898

Open Data